Matthew Perry Death: All Five Defendants Plead Guilty in Ketamine Overdose Case

The sudden and tragic loss of Matthew Perry, the beloved “Friends” star, sent shockwaves around the world. Now, nearly a year after his passing, a complex legal case has reached a critical junction, offering a clearer picture of the events that led to his death from acute effects of ketamine. Federal authorities have secured guilty pleas from all five individuals charged in connection with the overdose, closing a chapter on a case that exposed a shadowy network supplying the actor with the powerful drug.

How Does the Matthew Perry Case Impact Addiction and Celebrity Treatment?

The guilty pleas in this high-profile case cast a stark light on the vulnerabilities individuals face when battling addiction and depression, regardless of their fame or resources. It underscores a dangerous trend where illegal drug distribution networks can infiltrate the lives of those seeking help, bypassing legitimate medical channels. This case serves as a grim reminder of the critical importance of seeking treatment through licensed, ethical medical professionals and the severe legal consequences for those who exploit addiction for profit. The medical community is now grappling with the case’s implications for the responsible, monitored use of ketamine in treating depression.

The Central Figures in the Prosecution

The five defendants, ranging from Perry’s personal assistant to medical professionals, each played a distinct role in the chain of events. Their pleas paint a detailed picture of how the illicit ketamine was sourced and administered.

Kenneth Iwamasa, Perry’s 60-year-old live-in personal assistant, was the first to plead guilty. His agreement revealed he acted as a direct facilitator, procuring the drug and personally administering multiple injections to Perry daily. Court documents state he injected the actor six to eight times per day in his final days. It was Iwamasa who discovered Perry’s body in his home hot tub.

Dr. Salvador Plasencia, a 43-year-old Los Angeles-area doctor, admitted to selling Perry 20 vials of ketamine. Text messages revealed in his plea show a cynical attitude, with the doctor wondering how much “this moron will pay.” Despite witnessing Perry have adverse reactions to injections, including freezing up and spiking blood pressure, he continued to supply the drug and even instructed Iwamasa on injection techniques.

Erik Fleming, a 55-year-old acquaintance of Perry’s, served as the critical link to the drug’s source. He connected Perry’s assistant with a dealer he praised in texts as the “Ketamine Queen,” boasting her product was “amazing” and that she exclusively dealt with “high end and celebs.” He facilitated the delivery of 50 vials, including a batch sold for $6,000 just four days before Perry died.

Dr. Mark Chavez, a 55-year-old San Diego doctor, was the original source of the ketamine that Plasencia sold. Chavez admitted to obtaining the drug from a wholesale distributor under false pretenses. He has since surrendered his medical license.

Jasveen Sangha, a 42-year-old dual UK-US citizen known by the moniker “Ketamine Queen,” was the final defendant to plead guilty. Prosecutors identified her as the supplier of the lethal dose. Her plea agreement states she ran a drug business from her Los Angeles apartment, promoting herself as a celebrity dealer. A subsequent raid on her home uncovered large quantities of ketamine, cocaine, and methamphetamine.

Legal Outcomes and Sentencing

Each defendant now awaits sentencing, facing potentially decades in prison. The charges and maximum sentences are severe, reflecting the gravity of distributing a controlled substance resulting in death. Kenneth Iwamasa faces up to 15 years, Erik Fleming up to 25 years, Dr. Mark Chavez up to 10 years, Dr. Salvador Plasencia up to 40 years, and Jasveen Sangha faces the longest potential sentence of up to 45 years. Their sentencings are scheduled throughout the fall and winter.

The tragic death of Matthew Perry is a sobering lesson on the devastating intersection of addiction, illicit drug use, and the failure of medical ethics. While the legal process has held these five individuals accountable, the case forever highlights the profound loss of a talented actor and the ongoing struggle for those seeking help, reminding everyone that legitimate, supervised care is the only safe path to recovery.

---

Must Know

What was Matthew Perry’s cause of death?
Matthew Perry died from the acute effects of ketamine. The Los Angeles County Medical Examiner’s Office ruled his death an accident, with contributing factors including drowning, coronary artery disease, and the effects of buprenorphine, a medication used to treat opioid use disorder.

Who is the “Ketamine Queen” in the Matthew Perry case?
Jasveen Sangha is the defendant prosecutors identified as the “Ketamine Queen.” She admitted to running a drug distribution business and supplying the ketamine that led to Matthew Perry’s death. She pleaded guilty to multiple distribution charges.

How did Matthew Perry get the ketamine?
According to court documents, Perry was introduced to a supplier known as the “Ketamine Queen” by an acquaintance, Erik Fleming. His personal assistant, Kenneth Iwamasa, then facilitated the purchases and administered the injections, with some ketamine also being supplied by Dr. Salvador Plasencia.

What charges did the doctors face?
Dr. Salvador Plasencia pleaded guilty to four counts of distribution of ketamine. Dr. Mark Chavez pleaded guilty to one count of conspiracy to distribute ketamine. Both were involved in sourcing and providing the illicit ketamine outside of legitimate medical practice.

Have all the defendants been sentenced?
No, as of this reporting, all five defendants have agreed to plead guilty but have not yet been sentenced. Their sentencing hearings are scheduled for dates in September, November, and December of this year.

What is the status of Matthew Perry’s estate?
This article focuses solely on the criminal case related to his death. The status of his estate is a separate civil legal matter and not addressed in these proceedings.